<ARTICLE> 5
<MULTIPLIER> 1,000
       
                             
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                         DEC-31-1997 
<PERIOD-START>                            JAN-01-1997
<PERIOD-END>                              JUN-30-1997
<CASH>                                      1,853,011
<SECURITIES>                                  100,138 
<RECEIVABLES>                               1,449,845 
<ALLOWANCES>                                   62,019 
<INVENTORY>                                   945,831 
<CURRENT-ASSETS>                            4,992,080       
<PP&E>                                      7,039,912      
<DEPRECIATION>                              2,883,445    
<TOTAL-ASSETS>                             12,288,903      
<CURRENT-LIABILITIES>                       3,699,847    
<BONDS>                                     2,501,817  
<PREFERRED-MANDATORY>                               0 
<PREFERRED>                                         0 
<COMMON>                                      355,564 
<OTHER-SE>                                  4,314,379       
<TOTAL-LIABILITY-AND-EQUITY>               12,288,903         
<SALES>                                     3,724,943          
<TOTAL-REVENUES>                            3,941,728          
<CGS>                                         929,557          
<TOTAL-COSTS>                               1,090,131          
<OTHER-EXPENSES>                            4,115,329<F1>   
<LOSS-PROVISION>                                    0<F2>  
<INTEREST-EXPENSE>                            123,090       
<INCOME-PRETAX>                             (712,096)      
<INCOME-TAX>                                  587,384      
<INCOME-CONTINUING>                       (1,299,480)     
<DISCONTINUED>                                      0  
<EXTRAORDINARY>                                     0      
<CHANGES>                                           0  
<NET-INCOME>                              (1,299,480)
<EPS-PRIMARY>                                  (2.36) 
<EPS-DILUTED>                                  (2.36) 
<FN>

<F1>  Amounts include research and development, selling and general 
      administrative expenses, and asset impairment.

<F2>  The information called for is not given as the balances are not 
      individually significant.
</FN>